Regulatory Science to Advance Precision Medicine Forum: A Meeting by University of Rochester, PhRMA Foundation, and the University of Virginia

Summary: Meeting participants gathered to discuss emerging trends in precision medicine and impacts on regulatory decision-making. Particular focus was placed on 3D printing of medical products, combined with cell-based products (combination and Tissue Engineering/Regenerative Medicine products) and technologies and approaches that integrate and analyze genomic, proteomic, metabolomic, and/or epigenetic data for precision medicine.

Click here for an agenda and list of participants.

Click here to view a background article by Joan Adamo, et al. titled “Regulatory interfaces surrounding the growing field of additive manufacturing of medical devices and biologic products.”

Click here to view a background article by Joan Adamo, et al. titled “The integration of emerging omics approaches to advance precision medicine: How can regulatory science help?”

Details: The conference was held Wednesday, September 17, 2017 at PhRMA Foundation headquarters in Washington, D.C.

For more information about the conference, please call (202) 572-7756 or send an email to jwestphal@phrmafoundation.org.